Literature DB >> 1562166

Reticulocyte counting by flow cytometry. A comparison with manual methods.

A A Pappas1, R B Owens, J T Flick.   

Abstract

The reticulocyte count (RC) is a key diagnostic test in the evaluation, classification, and response to therapy of anemia. The RC, as determined by manual methods, has a frustrating inherent imprecision owing to its binomial counting statistics (i.e., low counts/low precision) and inaccuracy because of inter- and intraobserver variability as to what indeed is a reticulocyte. Fluorescent activated cytometric (FACS) analysis of reticulocytes by thiazole orange (TO) is a rapid, relatively simple, and precise method for counting reticulocytes. The automated method counts 10,000 cells or more vs. 1,000 cells counted by the manual method. Although inherently more precise, the FACS method may be inaccurate owing to the presence of Howell-Jolly bodies, nucleated red blood cells (RBCs), sickled cells, or giant platelets. The RC by FACS is well correlated with the manual method and the reference ranges are similar. A new parameter by FACS, the reticulocyte maturation index (RMI), provides an independent measurement of reticulocyte RNA content. Although the RMI does not correlate with RC either by FACS or manual methods, it does provide an independent parameter of erythropoietic activity and may be useful in predicting bone marrow engraftment or further subclassifying anemias. Determination by FACS of the RC offers significant advantages over manual methods in monitoring a patients erythropoietic response. However, one must be cognizant of potential pitfalls in the method.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562166

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  1 in total

1.  Correction of pseudoreticulocytosis in leukocytosis samples using the Sysmex XE-2100 analyzer depends on the type and number of white blood cells.

Authors:  Ahhyun Kim; Joonhong Park; Myungshin Kim; Jihyang Lim; Eun-Jee Oh; Yonggoo Kim; Yeon-Joon Park; Kyungja Han
Journal:  Ann Lab Med       Date:  2012-10-17       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.